84826-002-01 : NDC 2026 Code

84826-002-01 : Omidenepag Isopropyl ( Omlonti )

Additionally :

You can get information about “84826-002-01” NDC code in 84826-002-01 in HTML format

HTML | 84826-002-01 in TXT (Plain Text) format

TXT | 84826-002-01 in PDF (Portable Document Format)

PDF | 84826-002-01 in XML format

XML formats.

NDC Code : 84826-002-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "84826-002-01",
    "PackageDescription": "1 BOTTLE, PLASTIC in 1 CARTON (84826-002-01)  / 2.5 mL in 1 BOTTLE, PLASTIC",
    "NDC11Code": "84826-0002-01",
    "ProductNDC": "84826-002",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Omlonti",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Omidenepag Isopropyl",
    "DosageFormName": "SOLUTION/ DROPS",
    "RouteName": "OPHTHALMIC",
    "StartMarketingDate": "20220923",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA215092",
    "LabelerName": "Ocuvex Therapeutics, Inc.",
    "SubstanceName": "OMIDENEPAG ISOPROPYL",
    "StrengthNumber": ".02",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Prostaglandin E2 Receptor Agonist [EPC], Prostaglandin E2 Receptor Agonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-04-29",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250428",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}